---
title: "Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead"
id: "kff-health-news-0-copay-assistance-is-meant-to-defray-patient-drug-costs-some-insurers-keep-it"
canonical_url: "https://medichelpline.com/clinical-feed/kff-health-news-0-copay-assistance-is-meant-to-defray-patient-drug-costs-some-insurers-keep-it"
content_type: "clinical_feed_article"
specialty: "Research Highlights"
source_name: "KFF Health News"
source_url: "https://kffhealthnews.org/health-care-costs/copay-accumulator-adjustment-programs-patient-assistance-insurance-pharma-drugs/"
published_at: "2026-07-07T09:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/kff-health-news-0-copay-assistance-is-meant-to-defray-patient-drug-costs-some-insurers-keep-it
- **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md)
- **Primary Source:** KFF Health News
- **Source URL:** [Original Journal Publication](https://kffhealthnews.org/health-care-costs/copay-accumulator-adjustment-programs-patient-assistance-insurance-pharma-drugs/)
- **Published At:** 2026-07-07T09:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help him pay for a psoriatic arthritis medication he needs that costs more than $7,700 a month. Are you struggling to afford your health insurance? Have you decided to forgo coverage? Click here to contact KFF Health News and share your story. Each year, Amgen, which makes the drug, called Enbrel , sent the coupon card worth thousands of dollars, and that counted toward Gruber’s health insurance deductible and out-of-pocket maximum. Using the card, Gruber usually met that maximum by February, leaving his health insurance to fully cover his in-network medical costs and reducing his cost for the drug to $0 for the rest of the year. But this year, his new health insurer, Oscar HMO of Florida , pocketed the coupon card and required Gruber to pay for the drug until he satisfied the cost-sharing requirements on his own.
## Clinical Analysis & Structured Key Points
KFF Health News published a clinical update in Research Highlights on 07 Jul 2026. The item focuses on Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead. Review the original article for the full source wording and details.
## Related Clinical Research

- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)
- [Climate change worsens health for people with chronic illness](https://medichelpline.com/clinical-feed/stat-news-1-opinion-climate-change-is-making-people-with-chronic-illness-even-sicker.md)
- [Hyperuricemia and Gout in People Living with HIV: Systematic Review and Meta-analysis Protocol](https://medichelpline.com/clinical-feed/plos-one-6-urate-dysregulation-hyperuricemia-and-gout-among-people-living-with-hiv-a.md)

## Navigation
- [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.